Skip to main content
Clinical Trials/NCT00181051
NCT00181051SuspendedPhase 3

Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia

Gustave Roussy, Cancer Campus, Grand Paris1 site in 1 country128 target enrollmentStarted: February 1, 2003Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Suspended
Enrollment
128
Locations
1
Primary Endpoint
Influence of AEP guided anesthesia on recovery delay

Study Overview

Brief Summary

Index computed in real time from Auditory Evoked Potentials have been described parallel to depth of anesthesia. The goal of the study was to compare general anesthesia guided on Auditory Evoked Potentials monitoring to standrad practice in order to assess if AEP monitoring can improve recovery delay (main criteria) or intraoperative hemodynamic stability (secondary criteria). Patients were randomized in 2 groups, stratified by center. Group I : AEP guided anesthesia, Group II: Blind AEP record, standard practice.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •ASA status I-II patients
  • •aged 18 - 65 years
  • •scheduled for general surgery (except laparoscopic interventions) lasting longer than 1 hour.

Exclusion Criteria

  • •Body weight < 70% or > 150% ideal body weight
  • •neurological disorder and hearing disorders (being not able to communicate with the patient in a normal tone)
  • •use of any medication interfering with pharmacological effect of the study including alcohol misuse or drugs.

Outcomes

Primary Outcomes

Influence of AEP guided anesthesia on recovery delay

Secondary Outcomes

No secondary outcomes reported

Investigators

Study Sites (1)

Loading locations...

Similar Trials